Neil Goldstein
Geen lopende functies
Profiel
Neil I.
Goldstein is the founder of GenQuest, Inc. He worked as a Director at ImClone LLC from 1988 to 1997 and as a Director & Vice President at Molecular, Inc. and Cell Biology & Physiology.
He also served as the President & Chief Scientific Officer at Antyra, Inc. from 2003 to 2013.
Eerdere bekende functies van Neil Goldstein
Bedrijven | Functie | Einde |
---|---|---|
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | President | 01-12-2013 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Directeur/Bestuurslid | 01-01-1997 |
Cell Biology & Physiology | Directeur/Bestuurslid | - |
Molecular, Inc.
Molecular, Inc. Internet Software/ServicesTechnology Services Molecular, Inc. provides internet consulting services, which designs & builds internet-based solutions to help companies increase revenues and decrease operating costs. The company's services include strategic consulting, technology development & integration and usability testing to create e-business systems. Its finished products include customer portals, marketing campaign management tools and content management tools for clients including Analog Devices, Blue Cross Blue Shield of Massachusetts, Fidelity Investments and Staples. The company was founded by Ralph J. Folz in 1994 and is headquartered in Watertown, MA. | Directeur/Bestuurslid | - |
GenQuest, Inc.
GenQuest, Inc. Miscellaneous Commercial ServicesCommercial Services GenQuest, Inc. providesf professional services to government agencies, federal contractors, the education sector, and private businesses. Its service offerings encompass organizational consulting, staffing, and event management. The company was founded by Terri A. Giron-Gordon in 1995 and is headquartered in Albuquerque, NM. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Molecular, Inc.
Molecular, Inc. Internet Software/ServicesTechnology Services Molecular, Inc. provides internet consulting services, which designs & builds internet-based solutions to help companies increase revenues and decrease operating costs. The company's services include strategic consulting, technology development & integration and usability testing to create e-business systems. Its finished products include customer portals, marketing campaign management tools and content management tools for clients including Analog Devices, Blue Cross Blue Shield of Massachusetts, Fidelity Investments and Staples. The company was founded by Ralph J. Folz in 1994 and is headquartered in Watertown, MA. | Technology Services |
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Health Technology |
GenQuest, Inc.
GenQuest, Inc. Miscellaneous Commercial ServicesCommercial Services GenQuest, Inc. providesf professional services to government agencies, federal contractors, the education sector, and private businesses. Its service offerings encompass organizational consulting, staffing, and event management. The company was founded by Terri A. Giron-Gordon in 1995 and is headquartered in Albuquerque, NM. | Commercial Services |
Cell Biology & Physiology |